| Safety Study Using GSK573719 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease (NCT00515502) | GlaxoSmithKline | 2007-06-21 |
| A Study To Evaluate The Safety And Tolerability Of SB-656933-AAA Following Repeated Doses In Healthy Adult Subjects (NCT00504439) | GlaxoSmithKline | 2007-06-04 |
| Study To Examine Safety, Tolerability And Pharmacokinetics Of Intravenous Doses And Oral Dose Of GSK233705 (NCT00500461) | GlaxoSmithKline | 2007-06-04 |
| Nurse Tele-Consultations With Discharged COPD Patients Reduce the Numbers of Readmissions (NCT00918905) | Svendborg Hospital | 2007-06-01 |
| A 2 Part Study Examining Doses Of GSK961081 In Healthy Volunteers And Then In COPD Patients (NCT00478738) | GlaxoSmithKline | 2007-06-01 |
| A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK573719 In Healthy Volunteers (NCT00475436) | GlaxoSmithKline | 2007-05-14 |
| A Study To Investigate The Ability To Use 18FDG PET Scanning To Monitor The Effectiveness Of New Drugs In COPD Patients (NCT00472264) | Pfizer | 2007-05-01 |
| Viral Infections in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations (NCT00448604) | University Hospital, Geneva | 2007-05-01 |
| A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic Patients (NCT00463697) | GlaxoSmithKline | 2007-04-02 |
| Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD). (NCT00523991) | Boehringer Ingelheim | 2007-04-01 |
| 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00463567) | Novartis | 2007-04-01 |
| Adaptive Support Ventilation in the Weaning of COPD (NCT00969605) | Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital | 2007-04-01 |
| Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines (NCT00615992) | Boehringer Ingelheim | 2007-04-01 |
| A Dose Ascending, Study To Examine The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of GSK233705B. (NCT00453479) | GlaxoSmithKline | 2007-03-28 |
| A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK233705 In Healthy Volunteers. (NCT00453687) | GlaxoSmithKline | 2007-03-09 |
| Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study) (NCT00493974) | University of Minnesota | 2007-03-01 |
| A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler (NCT02172560) | Boehringer Ingelheim | 2007-03-01 |
| Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease (NCT00457977) | University of Minnesota | 2007-03-01 |
| Efficacy of Arm Training in COPD Patients (NCT00825032) | Villa Pineta Hospital | 2007-03-01 |
| Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD. (NCT00452400) | Boehringer Ingelheim | 2007-03-01 |
| Safety, Blood Levels and Effects of GW642444 (NCT00469040) | GlaxoSmithKline | 2007-02-28 |
| Effect of BIBW 2948 BS in COPD (NCT00423137) | Boehringer Ingelheim | 2007-01-17 |
| Inert Dusts and Pathology of Chronic Obstructive Pulmonary Disease (NCT00618137) | Medical University of Vienna | 2007-01-01 |
| Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease. (NCT00430300) | Pfizer | 2007-01-01 |
| ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies. (NCT00346749) | GlaxoSmithKline | 2006-12-01 |
| A Study To Assess The Safety And Tolerability Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT00372112) | GlaxoSmithKline | 2006-11-03 |
| Shortness Of Breath Questionnaire Validation Study (NCT00411372) | GlaxoSmithKline | 2006-11-01 |
| Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD) (NCT00400153) | Boehringer Ingelheim | 2006-11-01 |
| Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients. (NCT00388882) | Boehringer Ingelheim | 2006-10-04 |
| Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD) (NCT00396604) | Novartis | 2006-10-01 |
| Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT00422604) | GlaxoSmithKline | 2006-10-01 |
| Tiotropium / Respimat One Year Study in COPD. (NCT00387088) | Boehringer Ingelheim | 2006-09-01 |
| Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary Disease (NCT00376714) | GlaxoSmithKline | 2006-08-16 |
| Study to Assess GW642444 in Asthma Patients (NCT00381667) | GlaxoSmithKline | 2006-08-01 |
| A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease) (NCT00392587) | GlaxoSmithKline | 2006-08-01 |
| A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients. (NCT00359788) | Boehringer Ingelheim | 2006-07-01 |
| Real-Time Support for Exercise Persistence in COPD (NCT00373932) | University of Washington | 2006-05-01 |
| Spiriva® 18µg Once Daily in Chinese COPD Patients of Different Disease Severities (NCT00621582) | Boehringer Ingelheim | 2006-05-01 |
| Tiotropium + Procaterol vs Tiotropium + Placebo in COPD Patients (NCT00394485) | Otsuka Pharmaceutical, Inc., Philippines | 2006-05-01 |
| General Practice Quality Assurance Project. Chronic Obstructive Pulmonary Disease (COPD) Diagnosis and Treatment (NCT00319813) | Boehringer Ingelheim | 2006-04-19 |
| Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment. (NCT02172547) | Boehringer Ingelheim | 2006-04-01 |
| Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients (NCT00358488) | GlaxoSmithKline | 2006-04-01 |
| A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). (NCT00380796) | Centocor, Inc. | 2006-04-01 |
| Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00379730) | GlaxoSmithKline | 2006-03-21 |
| Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease (NCT00325897) | University of Minnesota | 2006-03-01 |
| Innate Immune Response in COPD (NCT02637219) | VA Puget Sound Health Care System | 2006-03-01 |
| A Dangerous Triad in Ageing and in Chronic Obstructive Pulmonary Disease (COPD) - Reduced Muscle Mass, Impaired Muscle Function and Malnutrition (NCT01179178) | Göteborg University | 2006-03-01 |
| Chronic Obstructive Pulmonary Disease Endpoints Study (NCT00358358) | GlaxoSmithKline | 2006-03-01 |
| A Randomised, Double-blind, Crossover Study of Ba679BR Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00292448) | Boehringer Ingelheim | 2006-02-01 |
| Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment (NCT00351676) | University of Alberta | 2006-02-01 |
| Symbicort in Chronic Obstruktive Pulmonary Disease (NCT00612976) | AstraZeneca | 2006-02-01 |
| Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique. (NCT00267917) | Boehringer Ingelheim | 2006-01-17 |
| Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation (NCT02172521) | Boehringer Ingelheim | 2006-01-01 |
| Evaluating Quality of Life for Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Lung Transplantation (NCT00675376) | Washington University School of Medicine | 2006-01-01 |
| Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease (NCT00279019) | GlaxoSmithKline | 2005-12-12 |
| Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints (NCT00292552) | GlaxoSmithKline | 2005-12-01 |
| SERETIDE Plus Tiotropium Versus Individual Components (NCT00325169) | GlaxoSmithKline | 2005-12-01 |
| Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary Disease (NCT02231320) | Boehringer Ingelheim | 2005-12-01 |
| Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease (NCT01809262) | Boehringer Ingelheim | 2005-12-01 |
| Study of GSK961081 in Healthy Volunteer Subjects (NCT00887406) | Theravance Biopharma | 2005-11-07 |
| Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00259909) | GlaxoSmithKline | 2005-11-02 |
| Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPD (NCT00263874) | Pfizer | 2005-11-01 |
| After Discharge Management of Low Income Frail Elderly (NCT00328848) | Summa Health System | 2005-10-01 |
| Randomized Controlled Trial of Mind-Body Breathing Therapy (in Chronic Obstructive Pulmonary Disease) To Improve Palliation of Dyspnea and Health-Related Quality of Life (NCT00243282) | US Department of Veterans Affairs | 2005-10-01 |
| Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Comparison to a Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (NCT02231346) | Boehringer Ingelheim | 2005-10-01 |
| Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00153075) | Boehringer Ingelheim | 2005-09-26 |
| Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease (NCT00281242) | University of Michigan | 2005-09-01 |
| Efficacy, Pharmacokinetics and Safety Comparison of Salmeterol Inhalation Powder Administered Via the HandiHaler® 2 and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02242227) | Boehringer Ingelheim | 2005-09-01 |
| Comparison of Alveolar Macrophages in Healthy Individuals Versus Individuals With COPD (NCT00281203) | University of Michigan | 2005-09-01 |
| T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease (NCT00281229) | University of Michigan | 2005-09-01 |
| Comparison of Alveolar Macrophages in Individuals With COPD Versus Smokers With Normal Pulmonary Function (NCT00281190) | University of Michigan | 2005-09-01 |
| Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations (NCT00281216) | University of Michigan | 2005-09-01 |
| Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272) (NCT00139932) | Merck Sharp & Dohme LLC | 2005-09-01 |
| GSK159802 In Healthy Male Subjects And Asthmatics (NCT00364273) | GlaxoSmithKline | 2005-08-24 |
| Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD (NCT00157339) | Eli Lilly and Company | 2005-08-01 |
| High Dose Trial in COPD (NCT00128440) | Boehringer Ingelheim | 2005-08-01 |
| Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00144859) | GlaxoSmithKline | 2005-07-01 |
| Dose Finding Study in COPD (NCT00122434) | Boehringer Ingelheim | 2005-07-01 |
| Study of SB681323 and Prednisolone on Biomarkers in COPD (Chronic Obstructive Pulmonary Disease) Patients (NCT00380133) | GlaxoSmithKline | 2005-06-01 |
| Special Survey Long-term Treatment With Tiotropium on COPD (NCT00638183) | Boehringer Ingelheim | 2005-04-01 |
| Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease (NCT02177318) | Boehringer Ingelheim | 2005-04-01 |
| Benefits of Lightweight Ambulatory Oxygen Systems for Individuals With Chronic Obstructive Pulmonary Disease (NCT00325754) | University of Minnesota | 2005-03-01 |
| Genetic Factors That Influence Chronic Obstructive Pulmonary Disease in Hispanics (NCT00106470) | University of Pittsburgh | 2005-02-01 |
| GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema) (NCT00269087) | GlaxoSmithKline | 2005-01-28 |
| A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations (NCT00116402) | University of Chicago | 2005-01-01 |
| Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD) (NCT00122694) | Groningen Research Institute for Asthma and COPD | 2005-01-01 |
| A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD (NCT00163098) | Pfizer | 2004-12-01 |
| Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease Exacerbations (NCT00115492) | GlaxoSmithKline | 2004-12-01 |
| Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma (NCT00152984) | Boehringer Ingelheim | 2004-12-01 |
| The Additional Value of Noninvasive Ventilation Next to Rehabilitation in Hypercapnic COPD Patients (NCT00135538) | Groningen Research Institute for Asthma and COPD | 2004-11-01 |
| Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease) (NCT00103922) | GlaxoSmithKline | 2004-11-01 |
| ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies. (NCT00144911) | GlaxoSmithKline | 2004-10-01 |
| Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma (NCT00354666) | GlaxoSmithKline | 2004-09-01 |
| An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005) (NCT00132730) | Merck Sharp & Dohme LLC | 2004-06-01 |
| Pharmacovigilance Study to Evaluate Safety of SERETIDE in Participants With Chronic Obstructive Pulmonary Disease (COPD) (NCT00662805) | GlaxoSmithKline | 2004-06-01 |
| Tolerability of Metoprolol-Succinate-ER and Carvedilol in COPD (NCT03370835) | VA Greater Los Angeles Healthcare System | 2004-06-01 |
| Study to Evaluate Efficacy and Safety of Inhaled BEA 2180 BR in COPD Patients (NCT02242279) | Boehringer Ingelheim | 2004-06-01 |
| Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease (NCT00106821) | Boehringer Ingelheim | 2004-06-01 |
| A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary Disease (NCT00219622) | Pfizer | 2004-05-01 |
| Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies. (NCT00355342) | GlaxoSmithKline | 2004-04-28 |